Evidence suggests that low in utero vitamin D levels may be associated with risk of asthma in offspring. 1 The Copenhagen
Their offspring attended 12 scheduled clinic visits until the age of 6 years, with additional acute care visits for any respiratory symptom; follow-up was through March 2017. Because of the delay in receiving ethical approval, 623 women of the 738 eligible were enrolled; 581 children were analyzed at the age of 3 years, at which time the study was unblinded.
Details of the study have been published. 2 Extension of the trial was planned in mid-2013 before any data were examined. The National Committee on Health Research Ethics approved the follow-up by October 2013. Oral and written informed consent for the follow-up was obtained from the parents. The protocol for the trial extension appears in Supplement 1. The primary outcome of the RCT 2 was persistent wheeze through the age of 3 years that was diagnosed by study pediatricians following a predefined, validated diagnostic algorithm. 3 The diagnosis was termed persistent wheeze during the first 3 years of life and asthma thereafter. Asthma at the age of 6 years was the primary outcome of the follow-up and was defined as fulfilling the diagnostic criteria at any point during childhood and needing inhaled corticosteroids at the age of 6 years. Prespecified secondary outcomes at the age of 6 years were lung function measurements, bronchial reactivity to methacholine, fractional exhaled nitric oxide concentration, allergic sensitization, and rhinitis. The primary outcome was analyzed using logistic regression and was adjusted for sex, season of birth, the mother's vitamin D level at randomization, and randomization group of a concomitant RCT on n-3 long-chain polyunsaturated fatty acids. 4 The yearly prevalence of persistent wheeze or asthma at the ages of 1 through 6 years was analyzed post hoc with a repeated-measures generalized estimating equation model. Secondary outcomes were analyzed using logistic and linear regression models. Analyses were performed using SAS version 9.4 (SAS Institute Inc) and a 2-sided statistical significance threshold of .05. No imputation was performed for missing data.
Results | At the age of 6 years, 545 of the 581 children (94%) were available for the analysis. Mothers of children lost to Supplemental content ). An analysis of the yearly prevalence of persistent wheeze or asthma through the age of 6 years also showed no effect of the supplementation (OR, 0.87 [95% CI, 0.59-1.28], P =.48; Figure) . No significant differences were observed for lung function outcomes, bronchial reactivity, fractional exhaled nitric oxide concentration, allergic sensitization, or rhinitis by the age of 6 years (Table) .
Discussion | High-dose compared with standard-dose vitamin D supplementation during pregnancy was not associated with the child's risk of asthma by the age of 6 years, at which time a diagnosis can be established using traditional measures. There also were no associations with lung function or bronchial hyperreactivity, which are key elements in asthma pathogenesis, and no association with allergy outcomes, suggesting that a benefit was not overlooked. The possible clinically important protective effect of vitamin D on persistent wheeze at the age of 3 years was not found at the age of 6 years.
The main limitations of the study are reduced statistical power, evidenced by the wide 95% CIs because the target sample was not reached, and the potential information bias from unblinding at the age of 3 years.
Future studies should investigate whether the effect of prenatal vitamin D supplementation is modified by environmental, dietary, or genetic factors. COMMENT & RESPONSE
Excess Deaths After Hurricane Maria in Puerto Rico
To the Editor Drs Santos-Lozada and Howard 1 estimated 1139 excess deaths in Puerto Rico from Hurricane Maria, which made landfall on September 20, 2017. They found that the observed death toll for September through November 2017 fell outside the 95% CIs of the mean death counts. Given the destructive effect of Hurricane Maria, it is understandable that these months would be outliers from the historical patterns observed on the island. However, we have concerns that their method might be flawed and their estimation inaccurate.
The authors established expected monthly deaths and historical variability (95% CIs) based on summary statistics of the death counts from 2010 through 2016. Excess deaths were calculated by comparing observed counts with the upper 95% CI bound. This approach did not account for long-term trends and seasonal patterns, which can have significant effects on mortality rates.
2 It also did not account for the significant changes in population size that have occurred in Puerto Rico over the past 3 decades. 3 As seen in the Table in the article, 1 this method was not able to accurately predict the observed prehurricane deaths during 3 months in 2017. In January, there were 2894 deaths, higher than the upper bound of 2739. In July, there were 2367 deaths, lower than the lower bound of 2413. In August, there were 2321 deaths, lower than the lower bound of 2370. Prior to a natural disaster, we would expect a monthly death count outside the 95% CI to be a rare event. However, in the study, 1 in 3 of 8 months (37.5% of the time) the observed death counts were outside the 95% CI. If their method based on the historical patterns was not able to accurately predict 2017 deaths prior to the hurricane, how can we be confident that the results for 2017 deaths after the hurricane are correct? Recently, the Puerto Rican government used a similar method to compare average deaths during the 4 posthurricane months of 2017 with the average from the previous 4 years. The government acknowledged that the official toll of 64 deaths was an underestimation and there might have been 1427 more deaths after the hurricane.
In Reply The arguments presented by Drs Cruz-Cano and Mead are mistaken in some important conceptual, empirical, and methodological aspects. We stated in our Research Letter that the estimates were conservative and that they did not consider population denominators. Cruz-Cano and Mead state that the methodology "did not account for long-term trends and seasonal patterns, which can have significant effects on mortality rates." However, our method 1 accounted for seasonal patterns because it modeled each individual month's expected deaths as the mean over the previous 7 years, and the variability in this series accounted for the uncertainty around it. When we analyzed a longer series of data going back to the year 2000, the results are similar.
2
The letter writers argue that our method did not account for changes in population size. We conducted a correlation analysis of the number of deaths and US Census Bureau population estimates, which showed no association between the number of deaths and population estimates in Puerto Rico from 2000 through 2016 (Pearson correlation coefficient = −0.26; P = .32). In fact, the number of deaths has remained stable over the last 10 or more years, ranging between 30 346 deaths in 2014 and 28 411 deaths in 2015. 3. Original protocol for phase 2, age 3-6.
Original protocol and protocol changes Original Protocol
The following is an English translation of the original protocol in Danish. 
Local Ethics

21
Background
22
Asthma, eczema and allergy are the most common chronic diseases among children and over the past 40 years, the 23 incidence of these diseases has increased in industrialized countries through yet unknown factors in the environment. 
46
The study is a double-blinded, placebo-controlled, randomized parallel group design. 800 pregnant women will be randomized in a 1:1 ratio to intake of either high dose vitamin D supplementation or placebo according to one of the 48 following regimes:
2) High dose vitamin D supplement (2400units daily) (+ guidance in recommended supplement of vitamin D (400units daily))
52
The regimes are administered orally as 2 tablets daily.
Blinding and randomization are carried out by the Capital Region Pharmacy and stratified according to treatment group 54 in the fish oil intervention study (ClinicalTrials.gov: NCT00798226). This allows for equal numbers receiving high 55 dose vitamin D supplementation in both the fish oil active group and the fish oil placebo group.
56
The intervention is initiated at the beginning of the third trimester (pregnancy week 24) and continued until 1 st visit to
Based on the previous studies, it is expected that a large proportion of the participating women will have a daily low Vitamin D level, and therby vitamin D supplementation to these women will be a health benefit. The control group 87 receive recommended dose of vitamin D, and ethical problems in relation to sufficient treatment of the control group is 88 thereby not a problem.
necessary for future recommendations of vitamin D intake.
Briefly, these encompass introduction of novel assessments, including neurological development, growth, systemic immune status and airway mucosal immune status. 
Original statistical analysis plan and changes
Outcome definitions:
Description: Asthma is diagnosed according to the same predefined algorithm of recurrent troublesome lung symptoms,
189
response to treatment and relapse after withdrawal of treatment, which was used for persistent wheeze at age 0-3.
algorithm at any point during the first 6 years of life and still needing inhaled corticosteroids at age 6 to remain well 
